ATE528307T1 - Imidazopyridin-2-onderivate als inhibitoren von endothellipase - Google Patents

Imidazopyridin-2-onderivate als inhibitoren von endothellipase

Info

Publication number: ATE528307T1
Authority: AT; Austria
Prior art keywords: alkyl; cycloalkyl; aryl; bicyclic; ocoa
Prior art date: 2006-03-28

Application number

AT07723584T

Other languages

English (en)

Inventor

Gerhard Zoller

Stefan Petry

Markus Follmann

Guenter Mueller

Norbert Tennagels

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-03-28

Filing date

2007-03-26

Publication date

2011-10-15

2007-03-26 Application filed by Sanofi Sa filed Critical Sanofi Sa

2011-10-15 Application granted granted Critical

2011-10-15 Publication of ATE528307T1 publication Critical patent/ATE528307T1/de

Links

239000003112 inhibitor Substances 0.000 title abstract 2
JXXWJMUPNZDILL-UHFFFAOYSA-N imidazo[4,5-b]pyridin-2-one Chemical class C1=CC=NC2=NC(=O)N=C21 JXXWJMUPNZDILL-UHFFFAOYSA-N 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 17
125000003118 aryl group Chemical group 0.000 abstract 6
-1 Bicyclic imidazolone derivatives Chemical class 0.000 abstract 4
102100031375 Endothelial lipase Human genes 0.000 abstract 3
101710087274 Endothelial lipase Proteins 0.000 abstract 3
241000972349 Ocoa Species 0.000 abstract 3
125000002619 bicyclic group Chemical group 0.000 abstract 3
125000000623 heterocyclic group Chemical group 0.000 abstract 3
239000003814 drug Substances 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 2
125000001072 heteroaryl group Chemical group 0.000 abstract 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000002947 alkylene group Chemical group 0.000 abstract 1
230000003178 anti-diabetic effect Effects 0.000 abstract 1
230000002402 anti-lipaemic effect Effects 0.000 abstract 1
239000003472 antidiabetic agent Substances 0.000 abstract 1
125000004104 aryloxy group Chemical group 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
125000004438 haloalkoxy group Chemical group 0.000 abstract 1
125000001188 haloalkyl group Chemical group 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
230000004060 metabolic process Effects 0.000 abstract 1
125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
QWRBIGGBOGLFFP-UHFFFAOYSA-N n-hexyl-1-methyl-2-oxoimidazo[4,5-b]pyridine-3-carboxamide Chemical compound C1=CC=C2N(C)C(=O)N(C(=O)NCCCCCC)C2=N1 QWRBIGGBOGLFFP-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000003107 substituted aryl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT07723584T 2006-03-28 2007-03-26 Imidazopyridin-2-onderivate als inhibitoren von endothellipase ATE528307T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102006014685A DE102006014685A1 (de)	2006-03-28	2006-03-28	Imidazo-pyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholiphasen
PCT/EP2007/002637 WO2007110215A1 (en)	2006-03-28	2007-03-26	Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase

Publications (1)

Publication Number	Publication Date
ATE528307T1 true ATE528307T1 (de)	2011-10-15

Family

ID=38179814

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07723584T ATE528307T1 (de)	2006-03-28	2007-03-26	Imidazopyridin-2-onderivate als inhibitoren von endothellipase

Country Status (14)

Country	Link
US (1)	US7897616B2 (de)
EP (1)	EP2001878B1 (de)
JP (1)	JP2009531356A (de)
KR (1)	KR20080104341A (de)
CN (1)	CN101405288A (de)
AT (1)	ATE528307T1 (de)
AU (1)	AU2007229708A1 (de)
BR (1)	BRPI0709211A2 (de)
CA (1)	CA2647422A1 (de)
DE (1)	DE102006014685A1 (de)
MX (1)	MX2008012126A (de)
NO (1)	NO20084419L (de)
TW (1)	TW200815434A (de)
WO (1)	WO2007110215A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
UY31968A (es)	2008-07-09	2010-01-29	Sanofi Aventis	Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
EP2351744B1 (de)	2008-10-17	2015-01-07	Shionogi & Co., Ltd.	Essigsäureamidderivat mit hemmender wirkung auf vaskuläre endothellipase
WO2011034741A1 (en) *	2009-09-15	2011-03-24	Merck Sharp & Dohme Corp.	Imidazopyridin-2-one derivatives
US9556201B2 (en) *	2009-10-29	2017-01-31	Glaxosmithkline Llc	Bicyclic pyridines and analogs as sirtuin modulators
US8754113B2 (en)	2009-12-15	2014-06-17	Shionogi & Co., Ltd.	Oxadiazole derivative having endothelial lipase inhibitory activity
EP2582709B1 (de)	2010-06-18	2018-01-24	Sanofi	Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
WO2012030165A2 (ko)	2010-08-31	2012-03-08	서울대학교산학협력단	P P A R δ 활성물질의 태자재프로그래밍용도
WO2013048928A1 (en)	2011-09-27	2013-04-04	Bristol-Myers Squibb Company	Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
WO2013049096A1 (en)	2011-09-27	2013-04-04	Bristol-Myers Squibb Company	Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
WO2013048982A1 (en)	2011-09-27	2013-04-04	Bristol-Myers Squibb Company	Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
WO2013048942A1 (en)	2011-09-30	2013-04-04	Bristol-Myers Squibb Company	Quinolinone carboxamide inhibitors of endothelial lipase
US8993557B2 (en)	2011-09-30	2015-03-31	Bristol-Myers Squibb Company	Pyridinedione carboxamide inhibitors of endothelial lipase
US8933235B2 (en)	2011-09-30	2015-01-13	Bristol-Myers Squibb Company	Pyridinedione carboxamide inhibitors of endothelial lipase
WO2013151877A1 (en)	2012-04-03	2013-10-10	Bristol-Myers Squibb Company	Pyrimidinedione carboxamide inhibitors of endothelial lipase
WO2013151923A1 (en)	2012-04-03	2013-10-10	Bristol-Myers Squibb Company	Pyrimidinone carboxamides as inhibitors of endothelial lipase
WO2014011513A1 (en)	2012-07-09	2014-01-16	Bristol-Myers Squibb Company	Sulfonyl containing benzothiazole inhibitors of endothelial lipase
EP2870152B1 (de)	2012-07-09	2016-09-28	Bristol-Myers Squibb Company	Amid- oder harnstoff-substituierte benzothiazolderivate als inhibitoren von endothellipase
EP2875007B1 (de)	2012-07-19	2016-08-24	Bristol-Myers Squibb Company	Amid-, harnstoff- oder sulfonamidgebundene benzothiazolinhibitoren der endothellipase
WO2014042939A1 (en)	2012-09-11	2014-03-20	Bristol-Myers Squibb Company	Ketone linked benzothiazole inhibitors of endothelial lipase
WO2015105749A1 (en)	2014-01-07	2015-07-16	Bristol-Myers Squibb Company	Sulfone amide linked benzothiazole inhibitors of endothelial lipase
US10597370B2 (en)	2016-06-06	2020-03-24	Bristol-Myers Squibb Company	2-(benzothiazol-2-yl)-2-cyano-acetamide derivatives and their use as endothelial lipase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE422799B (sv) *	1975-05-28	1982-03-29	Merck & Co Inc	Analogiforfarande for framstellning av 1,3-dihydroimidazo (4,5-b)pyridin-2-oner
WO2002030886A2 (en) *	2000-10-12	2002-04-18	Matthews Barry R	Heterocyclic angiogenesis inhibitors
DE102004005172A1 (de) *	2004-02-02	2005-08-18	Aventis Pharma Deutschland Gmbh	Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
CN101076334A (zh) *	2004-05-28	2007-11-21	默克公司	具有抗糖尿病活性的苯并脲类化合物
EP1861377B1 (de) *	2005-03-15	2010-12-29	Pfizer, Inc.	Benzimidazolonderivate als cb2-rezeptor-liganden
DE102005026762A1 (de) *	2005-06-09	2006-12-21	Sanofi-Aventis Deutschland Gmbh	Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen

2006
- 2006-03-28 DE DE102006014685A patent/DE102006014685A1/de not_active Withdrawn
2007
- 2007-03-26 AT AT07723584T patent/ATE528307T1/de not_active IP Right Cessation
- 2007-03-26 EP EP07723584A patent/EP2001878B1/de not_active Not-in-force
- 2007-03-26 MX MX2008012126A patent/MX2008012126A/es not_active Application Discontinuation
- 2007-03-26 TW TW096110266A patent/TW200815434A/zh unknown
- 2007-03-26 CN CNA2007800101778A patent/CN101405288A/zh active Pending
- 2007-03-26 BR BRPI0709211-3A patent/BRPI0709211A2/pt not_active IP Right Cessation
- 2007-03-26 AU AU2007229708A patent/AU2007229708A1/en not_active Abandoned
- 2007-03-26 KR KR1020087023444A patent/KR20080104341A/ko not_active Withdrawn
- 2007-03-26 CA CA002647422A patent/CA2647422A1/en not_active Abandoned
- 2007-03-26 WO PCT/EP2007/002637 patent/WO2007110215A1/en not_active Ceased
- 2007-03-26 JP JP2009501922A patent/JP2009531356A/ja not_active Abandoned
2008
- 2008-09-22 US US12/235,053 patent/US7897616B2/en not_active Expired - Fee Related
- 2008-10-21 NO NO20084419A patent/NO20084419L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2007229708A1 (en)	2007-10-04
US20090076068A1 (en)	2009-03-19
KR20080104341A (ko)	2008-12-02
NO20084419L (no)	2008-11-26
JP2009531356A (ja)	2009-09-03
US7897616B2 (en)	2011-03-01
CA2647422A1 (en)	2007-10-04
DE102006014685A1 (de)	2007-10-04
MX2008012126A (es)	2008-10-03
EP2001878A1 (de)	2008-12-17
EP2001878B1 (de)	2011-10-12
TW200815434A (en)	2008-04-01
BRPI0709211A2 (pt)	2011-06-28
CN101405288A (zh)	2009-04-08
WO2007110215A1 (en)	2007-10-04

Legal Events

Date	Code	Title	Description
2012-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE528307T1 (de)	2011-10-15	Imidazopyridin-2-onderivate als inhibitoren von endothellipase
PE20120120A1 (es)	2012-03-03	DERIVADOS DE 2H-PIRAZOLO[3,4-d]PIRIMIDINA-4,6(5H,7H)-DIONA, COMO INHIBIDORES DE PDE1
SG151286A1 (en)	2009-04-30	5-substituted-2-phenylamino-benzamide as mek inhibitor
PE20091573A1 (es)	2009-11-12	Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa
PE20090773A1 (es)	2009-07-23	Derivados de morfolina pirimidina
PE20061124A1 (es)	2006-10-13	Compuestos y derivados de dibencil amina
PE20060691A1 (es)	2006-09-06	Serinamidas sustituidas por benzoilo
ATE432259T1 (de)	2009-06-15	Pyridinderivate als dipeptedyl-peptidase-hemmer
PE20091201A1 (es)	2009-09-13	AMIDAS SUSTITUIDAS COMO INHIBIDORES DE LA TIROSINA QUINASA DE BRUTON (Btk)
AR079541A1 (es)	2012-02-01	Compuestos sustituidos de n-(1h-indazol-4-il) imidazo (1,2-a) piridin-3-carboxamida como inhibidores de cfms
PT1539734E (pt)	2006-05-31	Derivados da quinolil propil piperidina e sua utilizacao como agentes antimicrobianos
PE20071176A1 (es)	2008-02-08	Derivados diamina como inhibidores de leucotrieno a4 hidrolasa
CA2412718A1 (en)	2002-01-17	Viral polymerase inhibitors
MX2008013836A (es)	2008-11-10	Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
NO20075059L (no)	2007-10-08	Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase
ATE420639T1 (de)	2009-01-15	Antimykotische mittel
NZ612544A (en)	2015-04-24	Heterocyclic compounds suitable for the treatment of dyslipidemia
TW200640879A (en)	2006-12-01	Amide derivatives
EP1921077A4 (de)	2009-01-28	Mittel zur behandlung und/oder prävention von schlafstörungen
GT200600105A (es)	2007-02-14	Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos.
PE20061394A1 (es)	2006-12-15	Metabolitos de n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamidas
ATE476431T1 (de)	2010-08-15	Piperidin- und azetidinderivate als glyt1- inhibitoren
PE20091455A1 (es)	2009-10-22	Triazolopiridazinas como inhibidores de par1, su preparacion y uso como medicamentos
HRP20090264T1 (hr)	2009-06-30	Derivati fenil-piperazin metanona
RU2007139928A (ru)	2009-05-10	Производное бензимидазола и применение в качестве антагониста ангиотензина